Clinical Trial Update: Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 trial update of alvocidib in patients with chronic lymphocytic leukemia and prolymphocytic leukemia arising from chronic lymphocytic leukemia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia

Drugs mentioned

• Alvocidib (Flavopiridol)

Snippet

Sponsor: Sanofi | Conditions: Leukemia, Lymphocytic, Chronic | Phase 2 | Status: COMPLETED